NO901016L - Azolidinon-derivater. - Google Patents

Azolidinon-derivater.

Info

Publication number
NO901016L
NO901016L NO90901016A NO901016A NO901016L NO 901016 L NO901016 L NO 901016L NO 90901016 A NO90901016 A NO 90901016A NO 901016 A NO901016 A NO 901016A NO 901016 L NO901016 L NO 901016L
Authority
NO
Norway
Prior art keywords
azolidinon
derivatives
Prior art date
Application number
NO90901016A
Other languages
English (en)
Norwegian (no)
Other versions
NO901016D0 (no
Inventor
Steven W Goldstein
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO901016D0 publication Critical patent/NO901016D0/no
Publication of NO901016L publication Critical patent/NO901016L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90901016A 1987-09-04 1990-03-02 Azolidinon-derivater. NO901016L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (en) 1987-09-04 1987-09-04 Azolidinedione derivatives

Publications (2)

Publication Number Publication Date
NO901016D0 NO901016D0 (no) 1990-03-02
NO901016L true NO901016L (no) 1990-05-02

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901016A NO901016L (no) 1987-09-04 1990-03-02 Azolidinon-derivater.

Country Status (21)

Country Link
EP (1) EP0306251A3 (pt)
JP (1) JPS6471882A (pt)
KR (1) KR900008841B1 (pt)
CN (1) CN1022325C (pt)
AU (1) AU595467B2 (pt)
CS (1) CS273186B2 (pt)
DD (1) DD273381A5 (pt)
DK (1) DK488688A (pt)
EG (1) EG18591A (pt)
FI (1) FI901087A0 (pt)
HU (1) HU204832B (pt)
IL (1) IL87590A (pt)
MX (1) MX12896A (pt)
MY (1) MY103765A (pt)
NO (1) NO901016L (pt)
PH (1) PH24957A (pt)
PL (1) PL156798B1 (pt)
PT (1) PT88407B (pt)
WO (1) WO1989001775A1 (pt)
YU (1) YU46863B (pt)
ZA (1) ZA886507B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
KR101308227B1 (ko) * 2005-04-21 2013-09-13 이시하라 산교 가부시끼가이샤 니코틴산 유도체 또는 그의 염의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives

Also Published As

Publication number Publication date
YU167788A (en) 1990-06-30
ZA886507B (en) 1990-04-25
CN1031702A (zh) 1989-03-15
CN1022325C (zh) 1993-10-06
IL87590A (en) 1992-07-15
DK488688D0 (da) 1988-09-02
JPS6471882A (en) 1989-03-16
FI901087A0 (fi) 1990-03-02
NO901016D0 (no) 1990-03-02
HU204832B (en) 1992-02-28
EG18591A (en) 1993-06-30
HUT56106A (en) 1991-07-29
CS591188A2 (en) 1990-06-13
WO1989001775A1 (en) 1989-03-09
KR890005112A (ko) 1989-05-11
JPH0583554B2 (pt) 1993-11-26
AU595467B2 (en) 1990-03-29
PL274504A1 (en) 1989-05-02
DK488688A (da) 1989-04-07
CS273186B2 (en) 1991-03-12
YU46863B (sh) 1994-06-24
AU2184188A (en) 1989-03-09
PT88407B (pt) 1992-10-30
EP0306251A2 (en) 1989-03-08
KR900008841B1 (ko) 1990-11-30
EP0306251A3 (en) 1990-08-01
PT88407A (pt) 1989-07-31
PL156798B1 (pl) 1992-04-30
MX12896A (es) 1993-06-01
IL87590A0 (en) 1989-01-31
PH24957A (en) 1990-12-26
MY103765A (en) 1993-09-30
DD273381A5 (de) 1989-11-15

Similar Documents

Publication Publication Date Title
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI890685A0 (fi) Ljusstimulator.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
FI880462A (fi) Kraftaggregat.
DE3870513D1 (de) Tennisball.
FI880343A0 (fi) Brandalarmsystem.
DE3879348D1 (de) Fm-cw-radargeraet.
DE3877421D1 (de) Polyamidbenzazole.
FI883164A0 (fi) Kastanosperminestrar och -glykosider.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3866770D1 (de) Gerbstoff.
FI890204A0 (fi) Unfodringselement och -konstruktion foer vaermebehandlingsugnar.
DE3867805D1 (de) Paraocclusaler loeffel.
DE3873615D1 (de) Polycyanoarylthioether.
DE3879625D1 (de) Laseroszillator.